Literature DB >> 20498261

CD4 T-cell suppression by cells from Toxoplasma gondii-infected retinas is mediated by surface protein PD-L1.

Elizabeth Charles1, Sunil Joshi, John D Ash, Barbara A Fox, A Darise Farris, David J Bzik, Mark L Lang, Ira J Blader.   

Abstract

In the inflamed retina, CD4(+) T cells can cause retinal damage when they are not properly regulated. Since tissue expression of major histocompatibility complex (MHC) class II and costimulatory molecules is a key mechanism for regulating effector T cells, we tested the hypothesis that upregulation of these proteins in the retina contributes to the regulation of CD4 T cells. Here we report that in retinas infected with the protozoan parasite Toxoplasma gondii, MHC class II is upregulated on infiltrating leukocytes as well as on resident retinal cells, including photoreceptors. Flow cytometric analysis indicated that B7 costimulatory family members (CD80, CD86, ICOS-L, and programmed death ligand 2 [PD-L2]) were not expressed on class II(+) cells. In contrast, PD-L1 (also named B7-H1 or CD274) was expressed on the majority of both hematopoietic and resident retinal MHC class II-expressing cells. Retinal cells from Toxoplasma-infected animals were able to suppress T-cell activation in a PD-L1-dependent manner. Finally, we demonstrate that the expression of MHC class II and PD-L1 was critically dependent on gamma interferon (IFN-gamma) expression. These data suggest that retinal MHC class II and PD-L1 expression is a novel mechanism by which the retina protects itself from CD4 T-cell-mediated immune damage in ocular toxoplasmosis and other types of retinal immune responses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20498261      PMCID: PMC2916285          DOI: 10.1128/IAI.00117-10

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  58 in total

1.  CD45-positive cells of the retina and their responsiveness to in vivo and in vitro treatment with IFN-gamma or anti-CD40.

Authors:  Dale S Gregerson; Jing Yang
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-07       Impact factor: 4.799

2.  PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells.

Authors:  P'ng Loke; James P Allison
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-15       Impact factor: 11.205

3.  The innate immune response differs in primary and secondary Salmonella infection.

Authors:  Alun C Kirby; Ulf Yrlid; Mary Jo Wick
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

4.  PD-L1 and PD-L2 have distinct roles in regulating host immunity to cutaneous leishmaniasis.

Authors:  Spencer C Liang; Rebecca J Greenwald; Yvette E Latchman; Lucia Rosas; Abhay Satoskar; Gordon J Freeman; Arlene H Sharpe
Journal:  Eur J Immunol       Date:  2006-01       Impact factor: 5.532

5.  B7-H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis.

Authors:  Melissa M Mazanet; Christopher C W Hughes
Journal:  J Immunol       Date:  2002-10-01       Impact factor: 5.422

Review 6.  Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation.

Authors:  J Wayne Streilein
Journal:  J Leukoc Biol       Date:  2003-08       Impact factor: 4.962

7.  Blood monocytes consist of two principal subsets with distinct migratory properties.

Authors:  Frederic Geissmann; Steffen Jung; Dan R Littman
Journal:  Immunity       Date:  2003-07       Impact factor: 31.745

8.  Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion.

Authors:  Haidong Dong; Scott E Strome; Diva R Salomao; Hideto Tamura; Fumiya Hirano; Dallas B Flies; Patrick C Roche; Jun Lu; Gefeng Zhu; Koji Tamada; Vanda A Lennon; Esteban Celis; Lieping Chen
Journal:  Nat Med       Date:  2002-06-24       Impact factor: 53.440

9.  Interleukin-10 and pathogenesis of murine ocular toxoplasmosis.

Authors:  Fangli Lu; Shiguang Huang; Lloyd H Kasper
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

10.  Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease.

Authors:  Gary N Holland
Journal:  Am J Ophthalmol       Date:  2003-12       Impact factor: 5.258

View more
  11 in total

Review 1.  The molecular biology and immune control of chronic Toxoplasma gondii infection.

Authors:  Xiao-Yu Zhao; Sarah E Ewald
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

2.  Interleukin-6-driven inflammatory response induces retinal pathology in a model of ocular toxoplasmosis reactivation.

Authors:  Élise Rochet; Julie Brunet; Marcela Sabou; Luc Marcellin; Tristan Bourcier; Ermanno Candolfi; Alexander W Pfaff
Journal:  Infect Immun       Date:  2015-03-09       Impact factor: 3.441

3.  Toxoplasma gondii rhoptry 16 kinase promotes host resistance to oral infection and intestinal inflammation only in the context of the dense granule protein GRA15.

Authors:  Kirk D C Jensen; Kenneth Hu; Ryan J Whitmarsh; Musa A Hassan; Lindsay Julien; Diana Lu; Lieping Chen; Christopher A Hunter; Jeroen P J Saeij
Journal:  Infect Immun       Date:  2013-04-01       Impact factor: 3.441

4.  Avirulent uracil auxotrophs based on disruption of orotidine-5'-monophosphate decarboxylase elicit protective immunity to Toxoplasma gondii.

Authors:  Barbara A Fox; David J Bzik
Journal:  Infect Immun       Date:  2010-07-06       Impact factor: 3.441

5.  Role of the PD-1/PD-L1 Pathway in Experimental Trypanosoma cruzi Infection and Potential Therapeutic Options.

Authors:  Yanina Arana; Rosa Isela Gálvez; Thomas Jacobs
Journal:  Front Immunol       Date:  2022-06-23       Impact factor: 8.786

6.  MHC class II expression and potential antigen-presenting cells in the retina during experimental autoimmune uveitis.

Authors:  Deborah A Lipski; Rémi Dewispelaere; Vincent Foucart; Laure E Caspers; Matthieu Defrance; Catherine Bruyns; François Willermain
Journal:  J Neuroinflammation       Date:  2017-07-18       Impact factor: 8.322

Review 7.  Regulation of immunopathogenesis during Plasmodium and Toxoplasma infections: more parallels than distinctions?

Authors:  Noah S Butler; Tajie H Harris; Ira J Blader
Journal:  Trends Parasitol       Date:  2013-11-01

8.  Suppression of CD4 T-Cells in the spleen of mice infected with Toxoplasma gondii KI-1 tachyzoites.

Authors:  Won-Hee Kim; Eun-Hee Shin; Jae-Lip Kim; Seung-Young Yu; Bong-Kwang Jung; Jong-Yil Chai
Journal:  Korean J Parasitol       Date:  2010-12-16       Impact factor: 1.341

9.  siRNA Screening Identifies the Host Hexokinase 2 (HK2) Gene as an Important Hypoxia-Inducible Transcription Factor 1 (HIF-1) Target Gene in Toxoplasma gondii-Infected Cells.

Authors:  Matthew T Menendez; Crystal Teygong; Kristin Wade; Celia Florimond; Ira J Blader
Journal:  MBio       Date:  2015-06-23       Impact factor: 7.867

Review 10.  Disease Tolerance in Toxoplasma Infection.

Authors:  Stephanie J Melchor; Sarah E Ewald
Journal:  Front Cell Infect Microbiol       Date:  2019-06-06       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.